Business
ASX 200 rises 0.5%, Mesoblast plunges – Motley Fool Australia
The S&P/ASX 200 Index (ASX:XJO) went up 0.5% today, with the Mesoblast Limited (ASX:MSB) share price plunging 30.6% on FDA news.
The S&P/ASX 200 Index (ASX: XJO) rose by almost 0.5% today with the ASX continuing to climb.
There was one major plunge on the ASX:
Mesoblast Limited (ASX: MSB) share price crashes lower by 30.6%
Mesoblast released an announcement today on the scheduled meeting of the Oncologic Drugs Advisory Committee (ODAC) of the US FDA for the approval of Ryoncil in the treatment of steroid-refractory acute graft versus host disease in children.
The meeting is scheduled to take place on 13 August 202…
-
Noosa News18 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General16 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News19 hours agoBoy charged over E-Bike crash
-
Noosa News9 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050